Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

DENTSPLY SIRONA Inc. - Common Stock (NQ: XRAY )

18.70 +0.23 (+1.25%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about DENTSPLY SIRONA Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >
Earnings Scheduled For November 1, 2023
Companies Reporting Before The Bell • GSK (NYSE:GSK) is expected to report quarterly earnings at $1.07 per share on revenue of $9.37 billion. 
Via Benzinga
Looking Into Dentsply Sirona's Return On Capital Employed
Via Benzinga
3 Dental Supply Stocks You Can Sink Your Teeth Into
Long-term trends and margin improvements are driving growth for dental supply companies. 
Via The Motley Fool
SmileDirectClub Files For Chapter 11 Bankruptcy Just Four Years After $1.35 Billion IPO
SmileDirectClub Inc. (NASDAQ: SDC), a dental aligner manufacturer, has filed for bankruptcy just a few years after its remarkable $1.35 billion IPO. 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Bragar Eagel & Squire is Investigating Certain Officers and Directors of Dentsply, and Invivyd on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Material Weakness In Internal Control: Dentsply Stock Falls Despite Q2 Beat - What's Going On
Dentsply Sirona Inc (NASDAQ: XRAY) reported Q2 adjusted EPS of $0.51, down 26% from $0.69 a year ago, beating the consensus 
Via Benzinga
Baird Maintains Neutral Rating for Dentsply Sirona: Here's What You Need To Know
Via Benzinga
Dentsply Sirona Revises 2023 Guidance On Strong Q1 Earnings
Via Benzinga
Recap: Dentsply Sirona Q1 Earnings
Via Benzinga
Preview: Dentsply Sirona's Earnings
Via Benzinga
DENTSPLY INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Dentsply Sirona, Inc. - XRAY
From Kahn Swick & Foti, LLC
Via Business Wire
Parexel Announces Updates to Board of Directors
From Parexel International LLC
Via GlobeNewswire
DENTSPLY INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of Dentsply Sirona, Inc. - XRAY
From Kahn Swick & Foti, LLC
Via Business Wire
The Latest Analyst Ratings for Dentsply Sirona
Via Benzinga
Dentsply Sirona Earnings Preview
Via Benzinga
DENTSPLY ALERT: Bragar Eagel & Squire, P.C. is Investigating Dentsply Sirona, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire, P.C.
Via Business Wire
7 Stocks to Kick Out of the S&P 500
While not all bad companies, these S&P 500 stocks to sell don't deserve a spot in the index or your portfolio. 
Via InvestorPlace
DENTSPLY INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Dentsply Sirona, Inc. - XRAY
From Kahn Swick & Foti, LLC
Via Business Wire
Dentsply Sirona, Chico's FAS, Kontoor Brands And Other Big Stocks Moving Higher On Tuesday
U.S. stocks traded lower, with the Dow Jones dropping more than 150 points on Tuesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Dentsply Sirona's Better Than Expected Q4 Results Shows Stabilizing Organization
Via Benzinga
Earnings Scheduled For February 28, 2023
Companies Reporting Before The Bell • Gaotu Techedu (NYSE:GOTU) is expected to report earnings for its fourth quarter. 
Via Benzinga
Dentsply Sirona Announces Organization Restructure, Says 2023 To Be Transition Year
Via Benzinga
DENTSPLY INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Dentsply Sirona, Inc. - XRAY
From Kahn Swick & Foti, LLC
Via Business Wire
Got $1,000? 3 Growth Stocks to Buy That Could Double Your Money
It's just a matter of time. 
Via The Motley Fool
Dentsply Sirona Gets Analyst Upgrade After Positive Mixture Of Preliminary Results, Update
Via Benzinga
S&P 500 22Q4 Earnings Preview: A Reset In Growth Expectations
22Q4 earnings are forecasted at $447.07 billion (-2.2% y/y, -3.6% q/q) while revenue is forecasted at $3,697.7 billion (+4.1% y/y, -0.7% q/q). 
Via Talk Markets
Investor Sentiment Increases After S&P 500 Records Best Week Since June
The CNN Money Fear and Greed index showed further improvement in the overall market sentiment as the S&P 500 notched its best week since June. Data released Thursday showed further decline in the... 
Via Benzinga
Tyson Foods, AECOM And 3 Stocks To Watch Heading Into Monday
With US stock futures trading lower this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  During Wednesday's trading, 517 companies set new 52-week lows. 
Via Benzinga
Earnings Scheduled For November 14, 2022
Companies Reporting Before The Bell • Opiant Pharma (NASDAQ:OPNT) is estimated to report quarterly loss at $1.49 per share on revenue of $3.68 million. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.